Back
Innospec, Inc. 10K Form
Buy
56
IOSP
Innospec, Inc.
Last Price:
$77.88
Seasonality Move:
4.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | IOSP/Innospec, Inc. Quarterly |
| 2023-11-08 | 10Q | IOSP/Innospec, Inc. Quarterly |
| 2023-08-09 | 10Q | IOSP/Innospec, Inc. Quarterly |
| 2023-05-04 | 10Q | IOSP/Innospec, Inc. Quarterly |
| 2022-11-09 | 10Q | IOSP/Innospec, Inc. Quarterly |
| 2022-08-03 | 10Q | IOSP/Innospec, Inc. Quarterly |
Receive IOSP News And Ratings
See the #1 stock for the next 7 days that we like better than IOSP
IOSP Financial Statistics
Sales & Book Value
| Annual Sales: | $1.8B |
|---|---|
| Cash Flow: | $17.2M |
| Price / Cash Flow: | 70.8 |
| Annual Sales: | $52.35 |
| Price / Book: | 1.49 |
Profitability
| EPS (TTM): | -0.05880 |
|---|---|
| Net Income (TTM): | $-1.2M |
| Gross Margin: | $532.6M |
| Return on Equity: | -0.1% |
| Return on Assets: | -0.07% |
Innospec, Inc. Earnings Forecast
Key Innospec, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for IOSP is 28.86%.
-
The Selling, General & Administrative Expenses for IOSP have been equal to 17.02% of Gross Profit Margin.
-
The Research & Development expenses have been 2.59% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of IOSP is 1.93% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 14 years.
Innospec, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | IOSP |
| CUSIP: | 45768S |
| Website: | innospec.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 2.78 |
| Quick Ratio: | 1.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 54.95 |
|---|---|
| Forward P/E Ratio: | 13.98 |
IOSP Technical Analysis vs Fundamental Analysis
Buy
56
Innospec, Inc. (IOSP)
is a Buy
Is Innospec, Inc. a Buy or a Sell?
-
Innospec, Inc. stock is rated a BuyThe current Innospec, Inc. [IOSP] share price is $77.88. The Score for IOSP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.